Dana McGlothlin

1.1k total citations
20 papers, 762 citations indexed

About

Dana McGlothlin is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Dana McGlothlin has authored 20 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in Dana McGlothlin's work include Pulmonary Hypertension Research and Treatments (12 papers), Vascular Anomalies and Treatments (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Dana McGlothlin is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Vascular Anomalies and Treatments (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Dana McGlothlin collaborates with scholars based in United States. Dana McGlothlin's co-authors include Teresa De Marco, J. Eduardo Rame, William Grossman, Christian Heiß, Yerem Yeghiazarians, Nicolas Amabile, Petros Minasi, Raymond L. Benza, Evelyn M. Horn and Michael M. Givertz and has published in prestigious journals such as Circulation, American Journal of Respiratory and Critical Care Medicine and American Heart Journal.

In The Last Decade

Dana McGlothlin

20 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana McGlothlin United States 12 429 395 235 115 74 20 762
Nobuhiro Yaoita Japan 18 566 1.3× 439 1.1× 165 0.7× 95 0.8× 63 0.9× 38 913
B. Besse France 10 610 1.4× 564 1.4× 101 0.4× 246 2.1× 37 0.5× 33 976
Maria Laura Canale Italy 15 209 0.5× 551 1.4× 175 0.7× 122 1.1× 59 0.8× 77 895
Ikuko Nakamura Japan 10 140 0.3× 222 0.6× 210 0.9× 106 0.9× 89 1.2× 19 699
Bethan Freestone United Kingdom 16 115 0.3× 686 1.7× 271 1.2× 181 1.6× 52 0.7× 29 1.0k
Sandra Sanders‐van Wijk Netherlands 16 174 0.4× 792 2.0× 125 0.5× 136 1.2× 28 0.4× 36 1.0k
Stefanie Senger United States 13 174 0.4× 242 0.6× 128 0.5× 79 0.7× 24 0.3× 20 588
Jacek Godlewski Poland 9 120 0.3× 290 0.7× 172 0.7× 128 1.1× 30 0.4× 18 611
Xuebo Liu China 17 135 0.3× 366 0.9× 151 0.6× 316 2.7× 62 0.8× 59 795
Antonio Pazzola Italy 15 478 1.1× 112 0.3× 146 0.6× 57 0.5× 114 1.5× 43 767

Countries citing papers authored by Dana McGlothlin

Since Specialization
Citations

This map shows the geographic impact of Dana McGlothlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana McGlothlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana McGlothlin more than expected).

Fields of papers citing papers by Dana McGlothlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana McGlothlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana McGlothlin. The network helps show where Dana McGlothlin may publish in the future.

Co-authorship network of co-authors of Dana McGlothlin

This figure shows the co-authorship network connecting the top 25 collaborators of Dana McGlothlin. A scholar is included among the top collaborators of Dana McGlothlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana McGlothlin. Dana McGlothlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Sheng‐Fang, et al.. (2022). CTEPH: A Kaiser Permanente Northern California Experience. Thrombosis Research. 221. 130–136. 4 indexed citations
2.
Hung, Yun‐Yi, et al.. (2019). Amyloid cardiomyopathy in a large integrated health care system. American Heart Journal. 216. 42–52. 8 indexed citations
3.
McGlothlin, Dana, et al.. (2016). Influence of Pulmonary Hypertension on Adverse Outcomes Following Non-Cardiac Surgery. The Journal of Heart and Lung Transplantation. 35(4). S119–S120. 1 indexed citations
4.
Markova, Svetlana, Teresa De Marco, Joel Mefford, et al.. (2013). Association of CYP2C9*2 With Bosentan-Induced Liver Injury. Clinical Pharmacology & Therapeutics. 94(6). 678–686. 36 indexed citations
5.
Barnett, Christopher F., et al.. (2012). Abstract 13817: Methamphetamine Use is Common Among Patients with Pulmonary Arterial Hypertension (PAH) in California and is Associated with Worse Long-Term Survival Compared with Idiopathic PAH. Circulation. 126. 1 indexed citations
6.
7.
McGlothlin, Dana, Natalia S. Ivascu, & Paul M. Heerdt. (2012). Anesthesia and Pulmonary Hypertension. Progress in Cardiovascular Diseases. 55(2). 199–217. 41 indexed citations
8.
9.
McGlothlin, Dana. (2012). Classification of Pulmonary Hypertension. Heart Failure Clinics. 8(3). 301–317. 9 indexed citations
10.
Cogswell, Rebecca, et al.. (2012). Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: Application beyond pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 32(3). 293–298. 11 indexed citations
11.
McGlothlin, Dana & Teresa De Marco. (2011). Transplantation in Adults With Congenital Heart Disease. Progress in Cardiovascular Diseases. 53(4). 312–323. 13 indexed citations
12.
Caleshu, Colleen, Rahul Sakhuja, Robert L. Nussbaum, et al.. (2011). Furthering the link between the sarcomere and primary cardiomyopathies: Restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. American Journal of Medical Genetics Part A. 155(9). 2229–2235. 69 indexed citations
13.
McCabe, James M., Prashant D. Bhave, Dana McGlothlin, & John R. Teerlink. (2011). Running From Her Past. Circulation. 124(21). 2355–2361. 8 indexed citations
14.
15.
Amabile, Nicolas, Christian Heiß, Vivian Y. Chang, et al.. (2009). Increased CD62e+ Endothelial Microparticle Levels Predict Poor Outcome in Pulmonary Hypertension Patients. The Journal of Heart and Lung Transplantation. 28(10). 1081–1086. 89 indexed citations
16.
Khush, Kiran K., Gudaye Tasissa, Javed Butler, Dana McGlothlin, & Teresa De Marco. (2009). Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. American Heart Journal. 157(6). 1026–1034. 70 indexed citations
17.
Amabile, Nicolas, Christian Heiß, Petros Minasi, et al.. (2008). Circulating Endothelial Microparticle Levels Predict Hemodynamic Severity of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 177(11). 1268–1275. 174 indexed citations
18.
Mendelson, John, Dana McGlothlin, Debra Harris, et al.. (2008). The Clinical Pharmacology of Intranasal l-Methamphetamine. PubMed. 8(1). 4–4. 21 indexed citations
19.
Chatterjee, Kanu, Dana McGlothlin, & Andrew D. Michaels. (2008). Analytic Reviews: Cardiogenic Shock with Preserved Systolic Function: A Reminder. Journal of Intensive Care Medicine. 23(6). 355–366. 11 indexed citations
20.
McGlothlin, Dana & Teresa De Marco. (2007). Preoperative Risk Assessment of Pulmonary Arterial Hypertension Patients Undergoing General Surgery. Advances in Pulmonary Hypertension. 6(2). 66–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuhiro Yaoita Breakdown of academic impact, for papers by B. Besse Breakdown of academic impact, for papers by Maria Laura Canale Breakdown of academic impact, for papers by Ikuko Nakamura Breakdown of academic impact, for papers by Bethan Freestone Breakdown of academic impact, for papers by Sandra Sanders‐van Wijk Breakdown of academic impact, for papers by Stefanie Senger Breakdown of academic impact, for papers by Jacek Godlewski Breakdown of academic impact, for papers by Xuebo Liu Breakdown of academic impact, for papers by Antonio Pazzola
Rankless by CCL
2026